Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator
2016 · Scientific Reports · 49 citations
https://doi.org/10.1038/srep19534
G
Guoping Wang
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
1.5K
Citations
14
h-index
17
i10-index
Guoping Wang is an academic researcher from Duke University. The author has contributed to research in topics: Cancer-related Molecular Pathways & Renal cell carcinoma treatment & Metal complexes synthesis and properties. The author has an h-index of 14, co-authored 75 publications.
ORCID: 0000-0002-9166-8596Papers by this author
worksAttenuation of Activated eIF2α Signaling by ISRIB Treatment After Spinal Cord Injury Improves Locomotor Function
2021 · Journal of Molecular Neuroscience · 18 citations
https://doi.org/10.1007/s12031-021-01920-9
Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-52902-5
Trend analysis and prediction of the incidence and mortality of CKD in China and the US
2024 · BMC Nephrology · 12 citations
https://doi.org/10.1186/s12882-024-03518-w
Higher incidence of meibomian gland dysfunction in postmenopausal women with primary acquired nasolacrimal duct obstruction
2024 · International Ophthalmology · 4 citations
https://doi.org/10.1007/s10792-024-03041-9
Recurrence of macular edema in patients with branch retinal vein occlusion: a proteomic study
2024 · BMC Ophthalmology · 1 citations
https://doi.org/10.1186/s12886-024-03359-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat